Close it

Would you like to become a TBEC member? Please fill out the form below.

By becoming a TBEC member, you agree to endorse the values and the principles of the TB Europe Coalition, and agree with its membership rights and responsibilities.

Membership is free of charge.

TBEC membership rights

TBEC membership responsibilities












Posts tagged "TB"
TBEC Participation in the EU HIV/AIDS, Hepatitis and Tuberculosis Civil Society Forum Meeting

TBEC Participation in the EU HIV/AIDS, Hepatitis and Tuberculosis Civil Society Forum Meeting

The biannual face-to-face meeting of the EU HIV/AIDS, Hepatitis and Tuberculosis Civil Society Forum (CSF) took place on 17-18 June in Luxembourg. The forum has been established by the European Commission to facilitate the participation of European NGOs in policy development and implementation, as well as in information exchange activities. Initially established as a forum for HIV/AIDS civil society, in 2017 Civil Society Forum was extended to include hepatitis and tuberculosis NGOs, which allowed TBEC to formally become a CSF member. During the meeting, CSF members, including TBEC, provided updates on their work and discussed upcoming opportunities and challenges. TBEC also facilitated several sessions focused on political advocacy towards the EU. Since the last meeting in November 2018, CSF has been involved in a variety of advocacy activities. The Advocacy and Policy Working Group, coordinated by TBEC Board member Marine Ejuryan, has particularly focused its activities on ensuring that health is prioritised in the next EU long-term budget, the Multi-annual Financial Framework (MFF), as well as making sure that health stays high on the agenda of the new EU Commission and Parliament after the EU elections in May. During the meeting, CSF members agreed on the upcoming advocacy activities, which, More…

Call for Tenders n°Chafea/2016/Health/34, concerning the study of the socio-economic impacts of potential HIV/AIDS, viral hepatitis, STIs and TB

Call for Tenders n°Chafea/2016/Health/34, concerning the study of the socio-economic impacts of potential HIV/AIDS, viral hepatitis, STIs and TB

Dear colleagues, The new version of the call for tender n°Chafea/2016/Health/34, concerning the study of the socio-economic impacts of potential HIV/AIDS, viral hepatitis, sexually transmissible infections and tuberculosis was published. The main purpose of this contract is to carry out a study and produce a report in order to collect evidence and provide an assessment of the socio-economic impact of existing and future EU-level policy initiatives on HIV/AIDS, viral hepatitis, sexually transmissible infections (STI) and tuberculosis. Please promote to the your networks partners, in particular to those working in burden of diseases and cost analysis. Deadline: 18 September 2017 To view the details please click here. Thanks for your active collaboration. This blog is the product of an activity that has received funding under an operating grant from the European Union’s Health Programme (2014-2020). The content of this blog represents the views of the author only and is his/her sole responsibility; it cannot be considered to reflect the views of the European Commission and/or the Consumers, Health, Agriculture and Food Executive Agency or any other body of the European Union. The European Commission and the Agency do not accept any responsibility for use that may be made of the information More…

GOOD NEWS from KAZAKHSTAN:  Tuberculosis on decrease in the last 10 years

GOOD NEWS from KAZAKHSTAN: Tuberculosis on decrease in the last 10 years

According to the Ministry of Health and Social Development of the Republic of Kazakhstan, the country made a good progress in the tuberculosis incidence and mortality. Over the last 10 years the incidence of TB in Kazakhstan decreased by 2.2 times and the mortality rate decreased by 5 times. In 2015, the incidence decreased by 11.9% and amounted to 58.5 per 100 thousand population (in 2014 – 66.4), the mortality rate decreased by 22.4% and amounted to 3.8 per 100 thousand population (in 2014 – 4.9) (Health Ministry) The effective treatment of newly diagnosed patients with sensitive tuberculosis in 2015 improved and reached 87.6% compared to 86.4% in 2014 (WHO standard – 85%). “Today, all regions of the country are provided with modern equipment for diagnosis of tuberculosis, including its drug-resistant forms. The country has sufficient level of necessary medicines, “the ministry informed. This blog is the product of an activity that has received funding under an operating grant from the European Union’s Health Programme (2014-2020). The content of this blog represents the views of the author only and is his/her sole responsibility; it cannot be considered to reflect the views of the European Commission and/or the Consumers, Health, Agriculture and Food More…

High level event on sustainability of TB and HIV responses held in Tbilisi, Georgia

High level event on sustainability of TB and HIV responses held in Tbilisi, Georgia

From 28-30 September, a TBEC delegation attended a high level dialogue in Tbilisi ‘Road to Success’. We joined technical experts, civil society, donors, international agencies and Ministers to discuss the transition of some countries from donor support to domestic funding in Eastern Europe and Central Asia. The high level regional dialogue, hosted by the Georgian government and organised by the Eurasian Harm Reduction Network, the Global Fund, UNAIDS, UNDP, UNODS, UNFPA and WHO Europe is the first in a series of national dialogues which will develop plans for each countries for transition from Global Fund funding of TB and HIV programmes in the region. Although domestic financing of TB and HIV responses have been increasing throughout the years, countries are still highly dependent on Global Fund support, especially for services to key populations (81% dependent on external support), TB diagnostics like functioning of GeneXpert (94% dependent on Global Fund) and 2nd line TB drugs (66% dependent on Global Fund support). With figures such as these, in order to reach the Sustainable Development Goals’ targets of ending TB and HIV as public health threats by 2030, we need not only to sustain but also scale up our responses in the coming More…

IAS 2015: Review of clinics in Eastern Europe, southern Europe and Latin America of patients with HIV diagnosed with MDR-TB between 2011 and 2013

IAS 2015: Review of clinics in Eastern Europe, southern Europe and Latin America of patients with HIV diagnosed with MDR-TB between 2011 and 2013

The 8th IAS Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2015) is held in Vancouver, Canada from 19th July to 22nd July 2015. IAS is organized in partnership with the University of British Columbia (UBC) Division of AIDS, based at St. Paul’s Hospital, Providence Health Care. The event is a great opportunity for all those involved in the global response to HIV to meet and examine the latest scientific developments in HIV-related research. The registered organisations and participants present their research findings and share the latest scientific results with their counterparts to discuss how those developments can be applied in HIV-related programmes. One of the main six objectives of the IAS 2015 is to develop strategic discussions around the increasing challenges of TB, viral hepatitis and chronic co-morbidities. According to the presentation by Anna Schultze ‘Major challenges in clinical management of TB/HIV co-infected patients in Eastern Europe compared with Western Europe and Latin America’, patients in Eastern Europe where more likely to die from MDR-TB than those in Latin America and southern Europe. Patients who died in the Eastern European clinics had either not received drug susceptibility testing or had been placed on drugs that were not active against More…

Tuberculosis Advocates Participate in TBEC Advocacy Workshop

Tuberculosis Advocates Participate in TBEC Advocacy Workshop

On the 25 – 26 May 2015, the TB Europe Coalition organised a two-day Regional Advocacy training on TB control for civil society organisation (CSO) representatives and former TB patients. The training was held prior to the Wolfheze conference in the Hague, Netherlands.  Participants were CSO representatives as well as former TB patients involved in TB advocacy at the regional and national level in the WHO European Region. They were from six countries of Eastern Europe and Central Asia (EECA) and another former TB patient from the Netherlands. The training aimed to provide participants with improved knowledge on core TB advocacy skills and public speaking as well as sharing best practices and building contacts and relationships with other TB advocates from the region.  These skills were then immediately put into practice at the Wolfheze Conference. Four participants delivered presentations later that week during the Wolfheze conference. Three of them were former TB-patients.   Wolfheze conference 27-29 May 2015 The Wolfheze conference began in 1990 in the Netherlands in the village of Wolfheze near Arnhem. Since 1990 it has been organised every two years by KNCV Tuberculosis Foundation in collaboration with WHO Europe and ECDC.  The conference focuses on management and More…

Tuberculosis Wolfheze Workshops Kicking Off Next Week

Tuberculosis Wolfheze Workshops Kicking Off Next Week

The 17th Wolfheze Workshops is jointly organized by the World Health Organization Regional Office for Europe (WHO/Europe), the European Centre for Disease Prevention and Control (ECDC) and KNCV Tuberculosis Foundation on 27 May – 29 May 2015, in Hague, the Netherlands The Wolfheze movement dates back to 1990 when the first Regional meeting on TB control was organized in Wolfheze village in the Netherlands. The Wolfheze Workshops aim to strengthen tuberculosis (TB) control in the WHO European Region with the ultimate goal of elimination of tuberculosis. The every other year pan European workshops provide a platform for national TB programme managers, health authorities, laboratory experts, national TB surveillance correspondents, civil society organizations and other partners to share experiences, discuss achievements, challenges and way forward and build consensus. The main aim of the meeting is to review the Regional Action Plans and Frameworks and translating them to action. In addition the Wolfheze working groups will report on their work of the themes identified in 2013 for common action (Social Determinants, Health financing in relation to TB control, Active Case Finding and Childhood TB). For more information about the Wolfheze Workshops please visit : kncvtbc.org    ___________________________________________________________ This blog is the product More…

The TB Europe Coalition Visit to Belarus

The TB Europe Coalition Visit to Belarus

As part of a TB Europe Coalition (TBEC) series of field visit, three members of TBEC visited Belarus in November 2014. These visits have been to countries in the WHO European Region with a high burden of multidrug-resistant TB. To date TBEC has visited Moldova, Ukraine, Romania, Bulgaria, Latvia, Estonia, Lithuania, Georgia, Azerbaijan, Armenia, Belarus and Tajikistan. TBEC members met with several individuals and organisations in Minsk, Belarus, interested in TB. In addition to these meetings, the team participated in a two-day Conference “Community role in the life of TB affected people through Global Fund (GF) processes”. Defeat TB Together (DTT) facilitated the visit to Minsk. DTT is a republic-wide NGO, formed mostly of TB patients, doctors and nurses, starting to work on advocacy, care and support. The main objectives of the TBEC visit to Belarus, as with previous country visits, were to: Understand in greater detail the challenges for civil society organisations working on TB or related areas (including the financing of TB information giving and the broader local NGO landscape); To further involve Belarus NGOs in future TBEC activities; Explore potential opportunities for donors to support local NGOs in TB work. Co-facilitate a two-day workshop (or Conference) “Community More…

Azerbaijan Brings Quality Tuberculosis Care to Prisons

Azerbaijan Brings Quality Tuberculosis Care to Prisons

According to the World Health Organization (WHO), tuberculosis (TB) is a major public health problem in many prisons and infection rates are often more than 10 times higher than in the general population. Frequently overcrowded and poorly ventilated, many prisons also lack early detection and sound treatment programmes to combat the disease. However, in Azerbaijan—a country bordering Russia, Georgia, Armenia and Iran—a tuberculosis programme in the country’s  prisons is helping reverse the spread of the disease. Fifteen years ago, 7 in every 1000 Azerbaijan people were ill with TB. By last year, rates had fallen to 1 in every 1000 people, which is major progress. In 1995, supported by the International Committee of the Red Cross, the country introduced the WHO DOTS approach to enable TB care and control in all of the country’s prisons. The approach has fostered political commitment and financing for TB efforts in prisons as well as linking to the wider national TB programme and health services; enabled earlier diagnosis; provided standardized treatment with supervision and patient support; provided effective drug supply and management; and monitored and evaluated the programme. Azerbaijan’s national programme  has developed  in line with the WHO European Office’s Consolidated Action Plan to More…

TBEC joins Civil Society Organisations to Improve Global TB discourse Language

TBEC joins Civil Society Organisations to Improve Global TB discourse Language

10 March 2015 – TBEC Joins other Civil Society Organisations to Call for the Retirement of Stigmatising and Criminalising language from the Global TB Discourse The Community Research Advisors Group (CRAG) and other civil society organizations (including TBEC) sent an open letter to the International Union Against Tuberculosis and Lung Disease (the Union) calling for the retirement of stigmatizing and criminalizing language from the global TB discourse. At last year’s conference in Barcelona there were many abstracts and presentations that included words that the global TB community has agreed to no longer use because of their stigmatizing connotations. The letter emphasizes that as the organizer of the world’s largest TB conference, and as the publisher of the TB field’s flagship journal the Union has the opportunity to lead by example in this area and affect real change that others in TB research and practice will follow. On 12 March 2015, José Luis Castro (Executive Director of The Union) responded by thanking the group for voicing these concerns as well as expressed clear steps to improve communicating in a manner that embodies respect for all people affected by TB. For more information visit:  http://www.tbonline Source of the image: http://www.tbonline       More…

USAID launches new tuberculosis control program in Tajikistan

USAID launches new tuberculosis control program in Tajikistan

DUSHANBE (TCA) — The United States Ambassador to Tajikistan Susan Elliott and the United States Agency for International Development (USAID) on Wednesday launched the USAID Tuberculosis (TB) Control Program, a new regional program to improve diagnosis and treatment of tuberculosis in Tajikistan, the U.S. Embassy in Dushanbe said. The new program is an extension of TB control activities initiated under past USAID projects such as TB CARE I, Quality Health Care Project and the Dialogue on HIV and TB Project. While joint collaboration between USAID, the Tajik government and other partners to combat TB has resulted in stabilization of TB over the past five years, the latest Global TB Report confirms an alarming increase in rates of multi-drug resistant TB in all five Central Asian countries. This five-year USAID TB Control Program aims to reduce the burden of TB and the development of multi-drug resistant TB (MDR-TB) in Tajikistan. The program will focus on improving access to diagnosis and treatment for vulnerable groups, supporting a patient-centered system of care, and strengthening laboratories and other parts of the health system in Sughd and Khatlon provinces and the Rasht Valley, including policy development at the national level. Ambassador Elliott pointed out the More…

Summary of the research of  "The Role and Challenges for INGOs in tackling TB in Tajikistan"

Summary of the research of “The Role and Challenges for INGOs in tackling TB in Tajikistan”

My name is Zulfiya.  I am a new TB European Coalition Coordinator.  I am originally from   Tajikistan but have been living in the UK since 2012.   I  recently obtained a Master’s degree  from the London School of Economics and Political Science, for which I conducted research “The Role and Challenges of INGOs in tackling TB in Tajikistan”. Here is a summary of this thesis. Tuberculosis (TB) is the leading cause of death in many developing countries including Tajikistan.  The ineffectiveness  and lack of technical as well as financial resources of the government makes it difficult for the government to fight with the disease in isolation. As a result, many international organisations including INGOs, UN agencies and donor countries fill this gap through providing direct TB care services as well as building the capacity of the government to fight TB.  Additionally, they also aid patients and families to address the social determinants of TB as a means of prevention and mitigation. One of the most serious challenges facing Tajikistan relates to the growing problem of multi drug resistant – TB (MDR-TB). The country is among the 27 high MDR-TB burdened countries (WHO, 2010).  It is believed that Tajikistan has one of the highest rates More…

wink.pink